- Home
- TPG vs ALKS Comparison
TPG vs ALKS Comparison
Compare TPG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPG
- ALKS
- Stock Information
- Founded
- TPG 1992
- ALKS 1987
- Country
- TPG United States
- ALKS Ireland
- Employees
- TPG N/A
- ALKS N/A
- Industry
- TPG Investment Managers
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- TPG Finance
- ALKS Health Care
- Exchange
- TPG Nasdaq
- ALKS Nasdaq
- Market Cap
- TPG 6.2B
- ALKS 5.1B
- IPO Year
- TPG 2022
- ALKS 1991
- Fundamental
- Price
- TPG $63.48
- ALKS $29.05
- Analyst Decision
- TPG Buy
- ALKS Strong Buy
- Analyst Count
- TPG 13
- ALKS 13
- Target Price
- TPG $64.17
- ALKS $40.38
- AVG Volume (30 Days)
- TPG 1.9M
- ALKS 2.0M
- Earning Date
- TPG 08-06-2025
- ALKS 07-29-2025
- Dividend Yield
- TPG 2.74%
- ALKS N/A
- EPS Growth
- TPG N/A
- ALKS 21.99
- EPS
- TPG N/A
- ALKS 2.08
- Revenue
- TPG $3,887,230,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- TPG N/A
- ALKS N/A
- Revenue Next Year
- TPG $24.36
- ALKS $3.33
- P/E Ratio
- TPG N/A
- ALKS $13.99
- Revenue Growth
- TPG 43.35
- ALKS N/A
- 52 Week Low
- TPG $37.52
- ALKS $25.56
- 52 Week High
- TPG $72.98
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- TPG 69.47
- ALKS 60.08
- Support Level
- TPG $53.78
- ALKS $26.07
- Resistance Level
- TPG $65.03
- ALKS $28.73
- Average True Range (ATR)
- TPG 1.72
- ALKS 0.87
- MACD
- TPG 0.43
- ALKS 0.35
- Stochastic Oscillator
- TPG 86.22
- ALKS 97.94
About TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.